Viewing Study NCT00828594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-05-07 @ 6:35 PM
Study NCT ID: NCT00828594
Status: TERMINATED
Last Update Posted: 2013-04-11
First Post: 2009-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular carcinoma View
None dose-finding study View
None randomized trial View
None medical treatment View
None RAD001 View
None sorafenib View
None Advanced hepatocellular cancer (HCC) View